What is Brendan Bioscience?
Brendan Bioscience, LLC, founded in 2004, operates as an FDA-registered manufacturer specializing in Class 1 Analyte Specific Reagents. The company upholds an ISO 13485 certified GMP facility, demonstrating a commitment to stringent quality standards. Its core expertise lies in the production of a patented reagent component crucial for clinical researchers and CLIA-certified laboratories engaged in Delayed Food Sensitivity testing. Overseen by its founder, Dr. Brent Dorval, Brendan Bioscience is dedicated to advancing immunoassay development within the medical field.
How much funding has Brendan Bioscience raised?
Brendan Bioscience has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Brendan Bioscience?
With the recent influx of capital, Brendan Bioscience is poised for strategic expansion. The large-scale late-stage funding suggests a focus on scaling manufacturing capabilities, broadening market reach for its specialized reagents, and potentially investing in further research and development to enhance its immunoassay offerings. This backing will likely enable the company to solidify its market leadership in supporting advanced diagnostics for food sensitivity and other related medical research areas.
See full Brendan Bioscience company page
